Showing 41 - 60 results of 69,583 for search '(( 50 ((a decrease) OR (greater decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.42s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  5. 45

    Decreased frequency of sEPSCs in <i>Dyt1</i> heterozygous KO mice. by Fumiaki Yokoi (170876)

    Published 2015
    “…<p>(A) Representative traces for sEPSCs. <i>Dyt1</i> heterozygous KO mice had a significantly decreased frequency of sEPSCs (B), but no change in either the amplitude (C), or rise (D) and decay (E) times of these events. …”
  6. 46
  7. 47
  8. 48

    Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

    Published 2016
    “…Huh7.5 cells were transfected with the VR1-HA or the Netrin-1-HA plasmid and infected at a MOI of 0.1 the day after seeding. Intracellular HCV RNA was quantified by RT-qPCR at each time point (data are shown as mean ± standard deviation, <i>n</i> = 3, Wilcoxon test, <i>p</i> < 0.05). …”
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55

    IgG-mediated systemic anaphylaxis decreased in BasoDTR mice. by Kunie Matsuoka (400418)

    Published 2013
    “…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
  16. 56

    Loss of C9orf72 decreases mTOR activation. by Janet Ugolino (3359054)

    Published 2016
    “…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
  17. 57
  18. 58
  19. 59
  20. 60